Wall Street await Cantel Medical Corp. (NYSE:CMN) to release earnings on March, 10. Analysts forecast EPS of $0.33, down exactly $0.03 or 8.33% from 2014’s $0.36 EPS. The expected CMN’s profit could reach $13.86M giving the stock 50.87 P/E in case $0.33 earnings per share is reported. After releasing $0.41 EPS for the previous quarter, Cantel Medical Corp.’s analysts now forecasts -19.51% negative EPS growth. The stock increased 0.45% or $0.3 during the last trading session, hitting $67.15. Cantel Medical Corp. (NYSE:CMN) has risen 23.60% since August 3, 2015 and is uptrending. It has outperformed by 29.26% the S&P500.
The institutional sentiment increased to 1.26 in Q3 2015. Its up 0.30, from 0.96 in 2015Q2. The ratio increased, as 11 funds sold all Cantel Medical Corp. shares owned while 55 reduced positions. 20 funds bought stakes while 63 increased positions. They now own 42.99 million shares or 26.05% more from 34.11 million shares in 2015Q2.
Diker Management Llc holds 25.36% of its portfolio in Cantel Medical Corp. for 2.03 million shares. Brown Capital Management Llc owns 5.68 million shares or 5.52% of their US portfolio. Moreover, Sandhill Capital Partners Llc has 4.73% invested in the company for 249,560 shares. The Pennsylvania-based Conestoga Capital Advisors Llc has invested 4.31% in the stock. Teton Advisors Inc., a New York-based fund reported 521,505 shares.
Since March 13, 2015, the stock had 0 insider purchases, and 4 sales for $3.49 million net activity. Krakauer Andrew A sold 22,981 shares worth $1.25M. Berman Ann E sold 2,462 shares worth $139,526. Diker Charles M sold 27,415 shares worth $1.54M. Diker Mark N. sold 10,000 shares worth $566,440. The insider Hansen Jorgen B sold 1,500 shares worth $79,185.
Cantel Medical Corp. is a provider of infection prevention and control services and products in the healthcare market. The company has a market cap of $2.82 billion. The Company’s divisions include Endoscopy, Water Purification and Filtration, Healthcare Disposables, Dialysis and Specialty Packaging. It has 54.95 P/E ratio. The Company’s Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.